4.5 Review

Melanogenesis Inhibitors

Journal

ACTA DERMATO-VENEREOLOGICA
Volume 98, Issue 10, Pages 924-931

Publisher

ACTA DERMATO-VENEREOLOGICA
DOI: 10.2340/00015555-3002

Keywords

skin pigmentation; melasma; melanin; tyrosinase

Categories

Funding

  1. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore Start-Up Grant
  2. CSIR, TOUCH [BSC0302]

Ask authors/readers for more resources

Abnormally high production of melanin or melanogenesis in skin melanocytes results in hyperpigmentation disorders, such as melasma, senile lentigines or freckles. These hyperpigmentary skin disorders can significantly impact an individual's appearance, and may cause emotional and psychological distress and reduced quality of life. A large number of melanogenesis inhibitors have been developed, but most have unwanted side-effects. Further research is needed to better understand the mechanisms of hyperpigmentary skin disorders and to develop potent and safe inhibitors of melanogenesis. This review summarizes the current understanding of melanogenesis regulatory pathways, the potential involvement of the immune system, various drugs in current use, and emerging treatment strategies to suppress melanogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available